Clinical practice guidelines advise screening for latent tuberculosis using interferon gamma release assay and a plain chest radiograph in order to rule out abnormal modifications at baseline, before considering initiation of a biologic agent for the management of psoriasis [44,45]. The gene discussed is IFNG; the disease is psoriasis.